FIDSON HEALTHCARE PLC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.35 NGN | 0.00% |
|
-9.75% | -18.00% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 7,425 | 6,468 | 9,389 | 12,977 | 20,655 | 40,162 |
| Enterprise Value (EV) 1 | 14,786 | 13,627 | 17,363 | 21,992 | 33,430 | 57,931 |
| P/E ratio | -76.2 x | 15.9 x | 7.79 x | 3.49 x | 4.93 x | 11.1 x |
| Yield | 3.03% | 4.84% | 5.56% | 8.04% | 6.11% | 3.43% |
| Capitalization / Revenue | 0.46 x | 0.46 x | 0.51 x | 0.42 x | 0.51 x | 0.76 x |
| EV / Revenue | 0.91 x | 0.97 x | 0.95 x | 0.71 x | 0.82 x | 1.09 x |
| EV / EBITDA | 5.34 x | 4.63 x | 4.57 x | 3.4 x | 4 x | 5.54 x |
| EV / FCF | -5.97 x | -8.58 x | -8.07 x | -20.7 x | -7.08 x | -14.3 x |
| FCF Yield | -16.8% | -11.6% | -12.4% | -4.83% | -14.1% | -6.99% |
| Price to Book | 1.04 x | 0.67 x | 0.89 x | 0.94 x | 1.22 x | 2.08 x |
| Nbr of stocks (in thousands) | 1,650,000 | 2,294,996 | 2,294,996 | 2,294,996 | 2,294,996 | 2,294,996 |
| Reference price 2 | 4.500 | 2.818 | 4.091 | 5.655 | 9.000 | 17.50 |
| Announcement Date | 3/31/19 | 5/21/20 | 3/31/21 | 4/1/22 | 4/1/23 | 4/3/24 |
1NGN in Million2NGN
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 16,230 | 14,062 | 18,276 | 30,861 | 40,634 | 53,050 |
| EBITDA 1 | 2,770 | 2,942 | 3,796 | 6,474 | 8,352 | 10,458 |
| EBIT 1 | 2,029 | 2,244 | 3,089 | 5,779 | 7,454 | 9,249 |
| Operating Margin | 12.5% | 15.96% | 16.9% | 18.73% | 18.35% | 17.43% |
| Earnings before Tax (EBT) 1 | 160.9 | 575.7 | 1,773 | 4,718 | 5,781 | 5,917 |
| Net income 1 | -97.45 | 407.2 | 1,205 | 3,720 | 4,187 | 3,608 |
| Net margin | -0.6% | 2.9% | 6.59% | 12.05% | 10.3% | 6.8% |
| EPS 2 | -0.0591 | 0.1774 | 0.5251 | 1.621 | 1.824 | 1.572 |
| Free Cash Flow 1 | -2,477 | -1,587 | -2,150 | -1,061 | -4,720 | -4,050 |
| FCF margin | -15.26% | -11.29% | -11.77% | -3.44% | -11.61% | -7.63% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | 0.1364 | 0.1364 | 0.2273 | 0.4545 | 0.5500 | 0.6000 |
| Announcement Date | 3/31/19 | 5/21/20 | 3/31/21 | 4/1/22 | 4/1/23 | 4/3/24 |
1NGN in Million2NGN
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 7,361 | 7,159 | 7,974 | 9,015 | 12,775 | 17,769 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.658 x | 2.433 x | 2.101 x | 1.392 x | 1.53 x | 1.699 x |
| Free Cash Flow 1 | -2,477 | -1,587 | -2,150 | -1,061 | -4,720 | -4,050 |
| ROE (net income / shareholders' equity) | -1.32% | 4.85% | 12% | 30.6% | 27.3% | 19.9% |
| ROA (Net income/ Total Assets) | 6.69% | 6.87% | 8.12% | 12% | 12.2% | 11% |
| Assets 1 | -1,457 | 5,929 | 14,847 | 31,077 | 34,190 | 32,755 |
| Book Value Per Share 2 | 4.340 | 4.190 | 4.590 | 5.990 | 7.370 | 8.410 |
| Cash Flow per Share 2 | 0.3300 | 0.1300 | 1.400 | 0.8500 | 0.9200 | 4.700 |
| Capex 1 | 536 | 531 | 1,985 | 2,646 | 6,614 | 4,446 |
| Capex / Sales | 3.3% | 3.77% | 10.86% | 8.57% | 16.28% | 8.38% |
| Announcement Date | 3/31/19 | 5/21/20 | 3/31/21 | 4/1/22 | 4/1/23 | 4/3/24 |
1NGN in Million2NGN
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
14.35
NGN
Average target price
22.47
NGN
Spread / Average Target
+56.59%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.00% | 24.76M | |
| +20.81% | 43.34B | |
| +23.03% | 21.96B | |
| +13.30% | 14.09B | |
| +12.97% | 13.64B | |
| +39.74% | 11.43B | |
| -10.39% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +9.64% | 5.22B |
- Stock Market
- Equities
- FIDSON Stock
- Financials Fidson Healthcare Plc
